Voyager Therapeutics, Inc. (VYGR) has 70 open-market insider trades by 21 insiders since 2015. The most active filer is Robin Swartz, COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc. | 10% Owner | — | 2 | $178.0M | 2023-02-23 |
| EcoR1 Capital, LLC | 10% Owner | — | 2 | $12.5M | 2023-01-11 |
| Third Rock Ventures GP III, L.P. | 10% Owner | — | 4 | $11.9M | 2023-01-23 |
| Third Rock Ventures III, L.P. via Kevin P. Starr | 10% Owner | — | 2 | $6.6M | 2023-02-02 |
| Sanofi | — | — | 1 | $1.8M | 2015-11-16 |
| Jane Henderson | CFOVP | — | 2 | $1.4M | 2018-03-23 |
| Alfred Sandrock | CEOPres | — | 10 | $969K | 2026-04-02 |
| Bernard Ravina | — | — | 7 | $759K | 2018-04-10 |
| Robin Swartz | COO | — | 12 | $478K | 2026-02-24 |
| Dinah Sah Ph.D. | CSO | — | 1 | $469K | 2019-01-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alfred Sandrock | CEO & President | Sell | $45K | 2026-04-02 |
| Robin Swartz | COO & CBO | Sell | $24K | 2026-02-24 |
| Nathan D. Jorgensen | CFO | Sell | $18K | 2026-02-24 |
| Todd Alfred Carter | Chief Scientific Officer | Sell | $16K | 2026-02-24 |
| Alfred Sandrock | President | Sell | $54K | 2026-02-24 |
| Robin Swartz | COO & CBO | Sell | $13K |
Companies that share insiders with VYGR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-02-18 |
| Alfred Sandrock | President | Sell | $40K | 2026-02-18 |
| Todd Alfred Carter | Chief Scientific Officer | Sell | $11K | 2026-02-18 |
| Todd Alfred Carter | Chief Scientific Officer | Sell | $14K | 2026-02-10 |
| Alfred Sandrock | President | Sell | $46K | 2026-02-10 |
| Robin Swartz | COO & CBO | Sell | $18K | 2026-02-10 |
| Nathan D. Jorgensen | CFO | Sell | $37K | 2025-10-03 |
| Toby Ferguson | — | Sell | $71K | 2025-08-18 |
| Toby Ferguson | Chief Medical Officer | Sell | $35K | 2025-04-02 |
| Alfred Sandrock | President | Sell | $37K | 2025-04-02 |